[Studies on anti-atherosclerotic agents. II. Experimental studies of 1,3-propanediol bis(2-p-chlorophenoxyisobutyrate) (CLY-503) for anti-atherosclerotic agents].
D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy*; D001777:Blood Coagulation / Q000187:drug effects; D002087:Butyrates / Q000494:pharmacology* / Q000627:therapeutic use; D002199:Capillary Permeability / Q000187:drug effects; D003864:Depression, Chemical; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D008055:Lipids / Q000097:blood; D008297:Male; D051379:Mice; D010636:Phenols / Q000494:pharmacology / Q000627:therapeutic use; D011409:Propylene Glycols / Q000494:pharmacology / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats
D002087:Butyrates; D008055:Lipids; D010636:Phenols; D011409:Propylene Glycols